Article ; Online: A single dose of angiotensin-(1-7) resolves eosinophilic inflammation and protects the lungs from a secondary inflammatory challenge.
Inflammation research : official journal of the European Histamine Research Society ... [et al.
2024 Volume 73, Issue 6, Page(s) 1019–1031
Abstract: Objective: Angiotensin-(1-7) [Ang-(1-7)] is a pro-resolving mediator. It is not known whether the pro-resolving effects of Ang-(1-7) are sustained and protect the lung from a subsequent inflammatory challenge. This study sought to investigate the impact ...
Abstract | Objective: Angiotensin-(1-7) [Ang-(1-7)] is a pro-resolving mediator. It is not known whether the pro-resolving effects of Ang-(1-7) are sustained and protect the lung from a subsequent inflammatory challenge. This study sought to investigate the impact of treatment in face of a second allergic or lipopolysaccharide (LPS) challenge. Methods: Mice, sensitized and challenged with ovalbumin (OVA), received a single Ang-(1-7) dose at the peak of eosinophilic inflammation, 24 h after the final OVA challenge. Subsequently, mice were euthanized at 48, 72, 96, and 120 h following the OVA challenge, and cellular infiltrate, inflammatory mediators, lung histopathology, and macrophage-mediated efferocytic activity were evaluated. The secondary inflammatory stimulus (OVA or LPS) was administered 120 h after the last OVA challenge, and subsequent inflammatory analyses were performed. Results: Treatment with Ang-(1-7) resulted in elevated levels of IL-10, CD4 Conclusion: A single dose of Ang-(1-7) resolves lung inflammation and protect the lung from a subsequent inflammatory challenge highlighting its potential therapeutic for individuals with asthma. |
---|---|
MeSH term(s) | Animals ; Angiotensin I/therapeutic use ; Angiotensin I/pharmacology ; Angiotensin I/administration & dosage ; Peptide Fragments/pharmacology ; Peptide Fragments/therapeutic use ; Peptide Fragments/administration & dosage ; Lung/drug effects ; Lung/pathology ; Lung/immunology ; Lipopolysaccharides ; Ovalbumin/immunology ; Mice ; Male ; Macrophages/drug effects ; Macrophages/immunology ; Eosinophils/drug effects ; Eosinophils/immunology ; Mice, Inbred BALB C ; Inflammation/drug therapy ; Eosinophilia/drug therapy ; Eosinophilia/immunology ; Bronchoalveolar Lavage Fluid/immunology ; Bronchoalveolar Lavage Fluid/cytology |
Chemical Substances | angiotensin I (1-7) |
Language | English |
Publishing date | 2024-04-24 |
Publishing country | Switzerland |
Document type | Journal Article |
ZDB-ID | 1221794-3 |
ISSN | 1420-908X ; 1023-3830 |
ISSN (online) | 1420-908X |
ISSN | 1023-3830 |
DOI | 10.1007/s00011-024-01880-x |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 675: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.